Xlife Sciences AG (SWX:XLS)
Switzerland · Delayed Price · Currency is CHF 21.10
+0.10 (0.48%)
Last updated: Aug 21, 2025
Xlife Sciences AG Market Cap
Xlife Sciences AG has a market cap or net worth of 119.43 million as of August 22, 2025. Its market cap has decreased by -42.22% in one year.
Market Cap
119.43M
Enterprise Value
269.91M
Revenue
834.88K
Ranking
n/a
PE Ratio
4.58
Stock Price
21.10
Market Cap Chart
Since February 10, 2022, Xlife Sciences AG's market cap has decreased from 240.46M to 119.43M, a decrease of -50.33%. That is a compound annual growth rate of -17.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 119.43M | -18.11% |
| Dec 30, 2024 | 145.84M | -47.72% |
| Dec 29, 2023 | 278.96M | 77.76% |
| Dec 30, 2022 | 156.93M | -34.74% |
| Feb 10, 2022 | 240.46M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 225.12B |
| Novartis AG | 199.12B |
| Lonza Group AG | 40.05B |
| Galderma Group AG | 31.60B |
| Alcon | 31.58B |
| Sandoz Group AG | 21.20B |
| Straumann Holding AG | 15.31B |
| Sonova Holding AG | 13.75B |